NDC 10019-063

Adenosine

Adenosine

Adenosine is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corpora. The primary component is Adenosine.

Product ID10019-063_5bca8860-de02-4c7f-bb43-01dfe4aea139
NDC10019-063
Product TypeHuman Prescription Drug
Proprietary NameAdenosine
Generic NameAdenosine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2010-04-20
Marketing CategoryANDA / ANDA
Application NumberANDA076501
Labeler NameBaxter Healthcare Corpora
Substance NameADENOSINE
Active Ingredient Strength3 mg/mL
Pharm ClassesAdenosine Recep
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 10019-063-08

10 BOX in 1 PACKAGE (10019-063-08) > 1 SYRINGE, GLASS in 1 BOX (10019-063-07) > 2 mL in 1 SYRINGE, GLASS (10019-063-34)
Marketing Start Date2010-04-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10019-063-34 [10019006334]

Adenosine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA076501
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-20
Marketing End Date2010-09-30

NDC 10019-063-03 [10019006303]

Adenosine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA076500
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-04-20
Marketing End Date2012-03-31

NDC 10019-063-02 [10019006302]

Adenosine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA076500
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-04-20
Marketing End Date2012-03-31

NDC 10019-063-07 [10019006307]

Adenosine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA076501
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-20
Marketing End Date2010-09-30

NDC 10019-063-08 [10019006308]

Adenosine INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA076501
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-04-20
Marketing End Date2010-09-30

Drug Details

Active Ingredients

IngredientStrength
ADENOSINE3 mg/mL

Pharmacological Class

  • Adenosine Receptor Agonist [EPC]
  • Adenosine Receptor Agonists [MoA]

NDC Crossover Matching brand name "Adenosine" or generic name "Adenosine"

NDCBrand NameGeneric Name
0404-9809AdenosineAdenosine
0409-1932AdenosineADENOSINE
0641-6113AdenosineAdenosine
0703-8776AdenosineAdenosine
0703-8777AdenosineAdenosine
10019-063AdenosineADENOSINE
16714-180AdenosineAdenosine
16714-556AdenosineAdenosine
16714-972AdenosineAdenosine
16714-997AdenosineAdenosine
17478-542AdenosineAdenosine
17478-544AdenosineAdenosine
17478-953AdenosineAdenosine
23155-258AdenosineAdenosine
23155-259AdenosineAdenosine
25021-301adenosineadenosine
68083-101AdenosineAdenosine
68083-157AdenosineAdenosine
68083-156AdenosineAdenosine
70518-1232AdenosineAdenosine
71872-7035AdenosineAdenosine
50090-1548AdenosineAdenosine
51662-1345ADENOSINEADENOSINE
52584-026AdenosineAdenosine
55150-192AdenosineAdenosine
55150-193AdenosineAdenosine
55154-1279AdenosineAdenosine
55648-630ADENOSINEADENOSINE
63323-651AdenosineAdenosine
64679-630ADENOSINEADENOSINE
67457-856AdenosineAdenosine
67457-854adenosineadenosine
67457-855adenosineadenosine
67457-857AdenosineAdenosine
71872-7099AdenosineAdenosine
67457-859AdenosineAdenosine
67457-858AdenosineAdenosine
51662-1450ADENOSINEADENOSINE
0469-8234Adenocardadenosine
42491-1200Tissen ICM 10Adenosine
42491-1100Tissen NF 10Adenosine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.